We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Combo Product Postapproval Guidance Calls for Company Foresight
FDA Combo Product Postapproval Guidance Calls for Company Foresight
January 25, 2013
Makers of drug-device combination products are urged to anticipate postapproval changes they may wish to make, and develop protocols for preparing modification proposals, according to new FDA draft guidance.